Stock Faceoff: Iridium (IRDM) vs. EchoStar (SATS)

IRDM Winner: IRDM 29% below 200WMA SATS
Since publish IRDM +2.2% Since publish SATS +1.4% $24.86 → $25.40 $108.34 → $109.84 as of 2026-03-20

A mungbeans.io stock faceoff — March 14, 2026

The Matchup

Two satellite companies. One operates a constellation of 66 low-earth orbit satellites providing voice, data, and IoT connectivity to every square inch of the planet. The other is trying to survive a multi-billion-dollar debt restructuring by selling off some of the most valuable wireless spectrum in America.

Iridium Communications trades at $24.86, sitting 28.8% below its 200-week moving average — deep in the screener’s extreme value zone, where it’s been for 126 consecutive weeks. It generates $250 million in annual free cash flow, buys back shares aggressively, and has insider conviction buying. The market is pricing it like a company in decline. The business says otherwise.

EchoStar trades at $108.34, a staggering 260% above its 200WMA of $30.16. The stock has surged 437% since crossing below the line in May 2025, fueled by two landmark spectrum transactions: a $23 billion sale of 3.45 GHz and 600 MHz spectrum to AT&T, and an approximately $11 billion sale of AWS-3, AWS-4, and H-Block licenses to SpaceX. The company still carries a going-concern warning.

This isn’t a faceoff between two comparable investments. It’s a case study in what the 200-week moving average actually tells you — and what happens when a stock’s price completely detaches from its operating fundamentals.


Tale of the Tape

MetricIRDMSATS
Price$24.86$108.34
Market Cap$2.66B$29.1B
200-Week MA$34.93$30.16
% from 200WMA-28.8%+260.8%
Time Below Line126 weeks (current)0 (above)
Historical Touches29
Avg Return After Touch6.2%53.2%
Trailing P/E14.5xN/A (losses)
Forward P/E16.1xN/A
EV/EBITDA10.6xN/A
Revenue (TTM)$803M$16.4B
Revenue Growth5.2%-4.3%
Gross Margin71.5%40.1%
Operating Margin25.9%-15.3%
Net Margin17.0%-96.6%
ROE22.0%-111.3%
FCF (TTM)$250M-$1.74B
FCF Yield9.4%Negative
Total Debt$1.58B$31.0B
Debt/Equity387%533%
Current Ratio1.800.41
Insider Buying2 buys, $871K1 buy, $68K
Share Buyback-4.9% YoY+248% YoY (dilution)
Analyst Target$29.00 (+17%)$129.17 (+19%)
Beta0.692.21

The table is almost comical in its lopsidedness. On every fundamental metric that matters — profitability, cash flow, margins, capital allocation, balance sheet safety — Iridium dominates. EchoStar’s only advantage is the sheer scale of its revenue ($16.4B from the legacy DISH/Hughes businesses) and the speculative value of its remaining spectrum holdings.

But the market has spoken: SATS is up 437% in under a year. IRDM is down 29% from its long-term trend. The market isn’t pricing fundamentals — it’s pricing optionality on spectrum and restructuring. The question is whether that optionality is worth paying for.


Round 1: The 200-Week Signal

Iridium has been below its 200WMA for 126 consecutive weeks — the longest below-the-line episode in the screener’s data for this stock. That duration is unusual and worth examining. The average episode length is 27.8 weeks. At 126 weeks, this isn’t a temporary dislocation — it’s a sustained derating that suggests the market has fundamentally repriced the business.

But here’s what makes it interesting: the business hasn’t deteriorated. Revenue has grown modestly (5.2%), margins remain strong (71.5% gross, 25.9% operating), free cash flow is robust ($250M TTM), and management is aggressively buying back shares (4.9% of float retired in the last year, 16.7% over three years). Two insiders bought $871K worth of stock in the last twelve months. The signal is a company whose stock has disconnected from its cash generation — the classic setup for mean reversion, if you’re patient enough.

EchoStar crossed below the 200WMA in May 2025 and then rocketed 437% above it. The 9 historical touches average a 53.2% return, but that average is skewed by this most recent episode — a once-in-a-decade restructuring event driven by spectrum sales, not repeatable operational improvement. The 200WMA is irrelevant to the SATS thesis at this point; the stock is trading on deal flow and spectrum optionality, not on any mean-reversion framework.

Edge: IRDM. The 200WMA signal is the entire mungbeans.io framework, and IRDM is deep in the buy zone with intact fundamentals. SATS has completely left the framework — it’s a restructuring speculation, not a value signal.


Round 2: Business Quality

Iridium operates the only satellite constellation that covers 100% of Earth’s surface, including oceans and poles. The network is irreplaceable — there is no competitor with equivalent global coverage at L-band frequencies. The constellation was fully refreshed with Iridium NEXT (completed 2019), meaning capex requirements are minimal for the next decade. This creates a predictable free cash flow machine: $803 million in revenue flows through 71.5% gross margins and converts to $250 million in FCF after all expenses.

The growth story is IoT and direct-to-device. Iridium’s Project Stardust is bringing NB-IoT connectivity via satellite, with trials underway in mid-2025 and commercial launch planned for 2026. Deutsche Telekom has selected Iridium for NB-IoT direct-to-device connectivity. The Qualcomm Snapdragon integration (October 2025) puts Iridium data services into tactical radios for the U.S. military. The new 9604 module — combining satellite, LTE-M, and GNSS in one chip — ships in June 2026 and targets the massive industrial IoT market. None of this is priced into a stock trading at 10.6x EV/EBITDA.

EchoStar is a fundamentally different animal. The company absorbed DISH Network in January 2024, inheriting a declining pay-TV business, an ambitious but hemorrhaging wireless network (Boost Mobile), and — most importantly — roughly $50 billion worth of wireless spectrum accumulated over two decades. The operating businesses are in severe distress: TTM net loss of $14.5 billion, negative FCF of $1.74 billion, revenue declining 4.3%, and a current ratio of 0.41 that signals acute liquidity pressure. The going-concern warning in the company’s filings is not boilerplate — it reflects real uncertainty about the company’s ability to meet obligations.

What EchoStar has is spectrum. The $23 billion AT&T sale and $11 billion SpaceX deal demonstrate that the market recognizes enormous value in the frequencies EchoStar controls. Analysts suggest $30 billion or more in additional spectrum could be monetized. But this is an asset-liquidation thesis, not an operating-business thesis. The company is selling its crown jewels to service debt and fund operations. Each spectrum sale reduces the future optionality that the stock price is capitalizing.

Edge: IRDM. This isn’t close. Iridium is an operating business generating real cash from a monopoly asset. EchoStar is a distressed conglomerate monetizing spectrum to survive. One creates value; the other extracts it.


Round 3: Valuation & Price

Iridium at 14.5x trailing earnings, 10.6x EV/EBITDA, and a 9.4% FCF yield is genuinely cheap for a business with its characteristics. Monopoly infrastructure assets with 71% gross margins and minimal capex requirements typically trade at 15–25x EBITDA. The current valuation implies the market either doesn’t believe in the IoT/D2D growth story or is penalizing the 387% debt-to-equity ratio, which, while high, is serviced comfortably by $250M in annual FCF.

At $24.86, you’re paying $2.7 billion for a company that generates nearly a tenth of its market cap in free cash flow every year, owns the only global satellite network of its kind, and is actively shrinking the share count. The 9.4% FCF yield alone provides a compelling return even if the multiple never expands.

EchoStar at $108 is priced almost entirely on spectrum optionality. The operating businesses don’t support the valuation — they’re losing money. The $29.1 billion market cap requires continued successful spectrum monetization, debt restructuring, and an eventual path to operational profitability through Boost Mobile or some other wireless strategy. This is a bet on management execution in one of the most complex corporate restructurings in telecom history, led by Charlie Ergen, who is brilliant but has a decades-long track record of value-destructive capital allocation for minority shareholders.

The 248% year-over-year share dilution is particularly damaging. Even if EchoStar successfully monetizes its spectrum, existing shareholders are being massively diluted in the process. The per-share economics are eroding even as the headline market cap rises.

Edge: IRDM. 9.4% FCF yield and 10.6x EBITDA for a monopoly infrastructure asset versus a money-losing restructuring trading on spectrum optionality with massive dilution. The valuation gap is as clear as it gets.


Round 4: Risk Profile

Iridium risks: High leverage (387% D/E) is the primary concern, though the debt is long-dated and serviced by stable cash flows. Competitive risk from SpaceX’s Starlink Direct to Cell is real but overstated — Starlink operates in different frequency bands with different use cases, and Iridium’s L-band advantage in IoT/M2M applications (low power, global, narrowband) is structurally defensible. The 126-week duration below the 200WMA raises the question of whether the market knows something — but the fundamentals don’t support a thesis of structural decline.

EchoStar risks: Where to begin. Going-concern warning. $31 billion in debt. Negative $1.74 billion FCF. Current ratio of 0.41. Revenue declining. Net losses of $14.5 billion. 248% share dilution. Dependence on continued spectrum sales to fund operations. Regulatory risk on remaining spectrum transactions. Integration risk across DISH, Hughes, and Boost Mobile. Charlie Ergen’s governance track record. Beta of 2.21 meaning the stock will amplify any market selloff.

The risk asymmetry is extreme. Iridium’s worst case is continued multiple compression on a cash-flowing business — you collect the 9.4% FCF yield and wait. EchoStar’s worst case is a failed restructuring, additional dilution, and potential equity wipeout if spectrum sales stall or debt comes due before liquidity is secured.

Edge: IRDM. Iridium’s risks are manageable and well-defined. EchoStar’s risks are existential.


The Verdict

Winner: Iridium (IRDM)

This faceoff illustrates something important about the mungbeans.io framework: the 200-week moving average is a tool for identifying quality businesses at temporary discounts, not for chasing momentum in restructuring plays.

Iridium is exactly what the screener is designed to find. A monopoly infrastructure asset with 71% gross margins, $250 million in annual free cash flow, aggressive buybacks, insider conviction buying, and a 9.4% FCF yield — sitting 29% below its long-term trend line for reasons that don’t appear in the income statement or cash flow statement. The IoT/D2D growth story (Project Stardust, Qualcomm integration, NB-IoT launch in 2026) provides upside optionality that the market assigns zero value to at 10.6x EBITDA.

EchoStar is a genuinely interesting situation — the spectrum assets are worth tens of billions, and the AT&T and SpaceX transactions prove it. But it’s a restructuring trade, not a value investment. The operating businesses are in distress, the dilution is catastrophic, the balance sheet carries a going-concern warning, and the stock is 260% above its long-term moving average. This is not where the mungbeans framework generates alpha.

If you own SATS, you’re betting that Charlie Ergen can navigate the most complex telecom restructuring in a decade while building a viable wireless business from the remnants of DISH, all without further destroying per-share value. That’s a bet on one man’s execution against enormous structural headwinds. It’s positioning starts to open conversation about long dated put options. This is a company on its dying breath so far above its long term average the speculators have built a Tower of Babel and smart money is awaiting its imminent collapse.

If you own IRDM, you’re buying a cash-generating monopoly at a multi-year low and getting paid 9.4% in free cash flow yield to wait for the market to re-rate it. The growth catalysts are launching in 2026. The shares outstanding are shrinking. The insiders are buying.

One of these is investing. The other is speculating. The screener knows the difference.


This analysis is for informational purposes only and does not constitute investment advice. Always do your own research before making investment decisions.

View on the screener: IRDM | SATS

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.